Dianthus Therapeutics (DNTH) PT Raised to $130 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts DNTH Hot Sheet
Price: $88.55 -2.38%
Rating Summary:
17 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Rating Summary:
17 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Join SI Premium – FREE
H.C. Wainwright analyst Swayampakula Ramakanth raised the price target on Dianthus Therapeutics (NASDAQ: DNTH) to $130.00 (from $47.00) while maintaining a Buy rating.
You May Also Be Interested In
- Meridian Mining Plc (MNO:CN) PT Raised to GBP3.75 at BMO Capital
- Okta, Inc (OKTA) PT Raised to $230 at BMO Capital on 'AI and Virtuous Cycle Opportunity'
- Nutex Health (NUTX) PT Raised to $306 at Freedom Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
